Literature DB >> 26706386

Pathophysiology of Pulmonary Hypertension in Chronic Parenchymal Lung Disease.

Inderjit Singh1, Kevin Cong Ma2, David Adam Berlin2.   

Abstract

Pulmonary hypertension commonly complicates chronic obstructive pulmonary disease and interstitial lung disease. The association of chronic lung disease and pulmonary hypertension portends a worse prognosis. The pathophysiology of pulmonary hypertension differs in the presence or absence of lung disease. We describe the physiological determinants of the normal pulmonary circulation to better understand the pathophysiological factors implicated in chronic parenchymal lung disease-associated pulmonary hypertension. This review will focus on the pathophysiology of 3 forms of chronic lung disease-associated pulmonary hypertension: idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease, and sarcoidosis.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic obstructive pulmonary disease; Idiopathic pulmonary fibrosis; Pulmonary fibrosis; Pulmonary hypertension; Sarcoidosis

Mesh:

Year:  2015        PMID: 26706386     DOI: 10.1016/j.amjmed.2015.11.026

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  5 in total

1.  Pulmonary Hypertension Associated with Pulmonary Veno-occlusive Disease in Patients with Polycythemia Vera.

Authors:  Takayoshi Tachibana; Naoki Nakayama; Ayako Matsumura; Yuki Nakajima; Hiroyuki Takahashi; Takuya Miyazaki; Hideaki Nakajima
Journal:  Intern Med       Date:  2017-08-21       Impact factor: 1.271

Review 2.  Comorbidity in idiopathic pulmonary fibrosis - what can biomarkers tell us?

Authors:  Tiago M Alfaro; Carlos Robalo Cordeiro
Journal:  Ther Adv Respir Dis       Date:  2020 Jan-Dec       Impact factor: 4.031

3.  Transforming growth factor beta 1 induced endothelin-1 release is peroxisome proliferator-activated receptor gamma dependent in A549 cells.

Authors:  Shulin Xiang; Yi Zeng; Bin Xiong; Yueqiu Qin; Xia Huang; Yujie Jiang; Weigui Luo; Suren R Sooranna; Liao Pinhu
Journal:  J Inflamm (Lond)       Date:  2016-06-10       Impact factor: 4.981

Review 4.  The NLRP3 inflammasome in pathogenic particle and fibre-associated lung inflammation and diseases.

Authors:  Mutlay Sayan; Brooke T Mossman
Journal:  Part Fibre Toxicol       Date:  2016-09-20       Impact factor: 9.400

5.  Healthcare utilization, medical expenditure, and mortality in Korean patients with pulmonary hypertension.

Authors:  In-Chang Hwang; Goo-Yeong Cho; Hong-Mi Choi; Yeonyee E Yoon; Jin Joo Park; Jun-Bean Park; Seung-Pyo Lee; Hyung-Kwan Kim; Yong-Jin Kim; Dae-Won Sohn
Journal:  BMC Pulm Med       Date:  2019-10-30       Impact factor: 3.317

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.